AI / ML Innovations Inc.
https://aiml-innovations.com/ https://aiml-innovations.com/health-gauge/ https://www.healthgauge.com/solutions https://www.healthgauge.com/blog https://aiml-innovations.com/tech2health/ Revenue
Tech2Health, Projects US$5M Revenue from its First Commercial Contracts -3 multi-year contracts signed in the first month of operation-
- digital mental health services contracts provide access to 300,000 potential users…
Read more
https://aiml-innovations.com/wp-content/uploads/2021/09/AIML-News-Release-July-14-2021.pdf https://aiml-innovations.com/about-us/ AI/ML INNOVATIONS INC. AI/ML Innovations’ Strategic Partner, Tech2Health, Projects US$5M Revenue from its First Commercial Contracts
-3 multi-year contracts signed in the first month of operation- - digital mental health services contracts provide access to 300,000 potential users
July 14, 2021 ACCESSWIRE AI/ML Innovations Inc. (CSE: AIML) (OTCQB: AIMLF) (“AIML” or the “Company”), a company committed to acquiring
and advancing Artificial Intelligence/Machine Learning technologies that address urgent societal needs, is pleased to announce that its
strategic partner, Tech2Health, a France-based global provider of proprietary digital mental health and wellness products, has entered into
commercial contracts with three companies to provide digital mental health services to their employees and insured members.
Based on the number of individuals covered and standard industry usage rates,
Tech2Health estimates that these contracts may potentially generate an aggregate total of US$5 million of revenue over the 3-year life of the contracts.
AIML has a binding Letter of Intent to acquire a 70% undivided interest in the North American rights to Tech2Health’s complete portfolio of products and brands,
in addition to a 22.22% equity interest in Tech2Health’s global operations. “Tech2Health’s Qookka-branded mental wellness products were officially launched only one month ago,
and already the company has secured three substantial multi-year contracts” said Tim Daniels, Chairman of AIML.
“We are very pleased by the rapid pace of commercialization the Qookka product lines are experiencing,
as employers and insurers continue to step up their responsibility to help provide mental health support, as evidenced by these contracts.
This reaffirms our belief that the digital application of the treatment and support of mental health issues,
which has gone largely unaddressed until recently, is now realizing rapid adoption and global growth.
This bodes well for the future of Tech2Health and AIML.”
10-25-2023
Oct 25, 2023
NEXT SUPER STOCK (OTC: AIMLF) (CSE: AIML) CEO Pau Duffy
discusses partnership w $78 Billion EssilorLuxotica for AR/AI Smart Glasses which could transform trillion dollar healthcare market worldwide.
(EssilorLuxotica makes the RayBan Meta smart glasses for Facebook/Meta)
TELEGRAM channel: https://t.me/s/WallStreetReporter ?? Website: http://www.WallStreetReporter.com / @wallstreetreporter1843 For business inquiries:
JM@WallStreetReporter.com Terms of Use & SEC 17B disclosure: : DISCLAIMER: ONLY FOR MICK
https://investorshub.advfn.com/boards/profilea.aspx?user=1012
*The Board Monitor and herewithin , are not licensed brokers and assume NO responsibility for actions,
investments,decisions, or messages posted on this forum.
CONTENT ON THIS FORUM SHOULD NOT BE CONSIDERED ADVISORY NOR SOLICITATION
AUTHORS MAY HAVE BUYS OR SELLS WITH THE COMPANIES MENTIONED IN TRADING POSTERS SHOULD DUE DILIGENT BUYING OR SELLING.
ALL POSTING SHOULD BE CONSIDERED FOR INFORMATION ONLY. WE DO NOT RECOMMEND ANYONE BUY OR SELL ANY SECURITIES POSTED HEREWITHIN.
ANY trade entered into risks the possibility of losing the funds invested.
• There are no guarantees when buying or selling any security.Any
DISCLAIMER;
JUST TO MAKE SOME THINGS CLEAR
I AM NOT AH FINANCIAL ADVISIOR
& NOT AH BROKER.
I AM JUST AH REGULAR GENT DAT LIKES TO
CHAT CHATTER ON MANY COMPANIES.
SOME I OWN AH LOT I DON'T.
SO NOT RESPONSIBLE ANYTHING I DESCRIBE.
THE MICK.